Insights On Partnering
-
ICH E6(R3): Practical Steps For Implementation
12/14/2023
Watch this presentation to equip stakeholders with actionable strategies and a comprehensive understanding of the evolving clinical trial management landscape in the context of ICH guidelines.
-
Employing An FSP Partnerships Model In Non-Footprint Countries
11/6/2023
Maintaining a robust global presence has become a pressing demand. Review this collection of strategic avenues when navigating the clinical trial landscape to promote successful research initiatives.
-
Cell And Gene Therapy Development – 3 Key Challenges In 2023
10/29/2023
Considering the current landscape, here are three critical factors for cell and gene therapy developers to overcome obstacles and advance development.
-
Three Ways To Clear Your Clinical Trial Backlog
8/16/2022
Here are three ways a unique clinical trials network helps you move through trials and streamline future studies to protect your bottom line and enhance your patient care.
-
How To Differentiate Your CRO In Today’s Market
5/4/2023
Learn how a more holistic approach beyond therapeutic expertise can highlight a CRO’s ability to meet a more comprehensive range of needs.
-
Uncovering Hidden CRO Contract Costs Before Signing A Contract
1/22/2024
Navigating the complex landscape of clinical trials can be challenging. Utilize this reliable CRO Checklist to empower teams to stay ahead and safeguard every trial's budget effectively.
-
Outsourcing High Potent Oral Solid Dose Late-Stage Development: CDMO Insights
4/17/2024
View the webinar to discover outsourcing options for highly potent oral solid dose therapies, and learn how CDMOs can transfer, handle and deliver their product to clinic and to market.
-
Help CROs Choose The Best Software: FDA Guidance On Umbrella Trials
9/27/2023
Utilize this guidance as a valuable resource in navigating the evolving landscape of clinical research in innovative and transformative fields.
-
Regulatory Portfolio Management: From Bad To Gold
10/30/2023
Uncover how a multiphased approach helped a small biotech to organize its programs so that it could efficiently make decisions, timely adapt to changes in strategy, and better understand current activities.
-
Outsourcing Vendor Red Flag #3: Inaccurate Or Low Bids
11/8/2023
A bad feeling in your gut is a firm starting point, but strategies exist to substantiate a bid’s value based on more than the “sniff test.”